(Q38303686)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

review article

1 reference

title

Metabolic effects of resveratrol: addressing the controversies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Jacob L Bitterman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Jay H Chung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

1 reference

30 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Life Sciences

26 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

1473-1488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00018-014-1808-8

26 February 2020

exact match

0 references

cites work

Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Calorie restriction does not elicit a robust extension of replicative lifespan in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sir2 mediates longevity in the fly through a pathway related to calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Overlapping and distinct functions for a Caenorhabditis elegans SIR2 and DAF-16/FOXO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sir2-independent life span extension by calorie restriction in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

dSir2 in the adult fat body, but not in muscles, regulates life span in a diet-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 transgenic mice show phenotypes resembling calorie restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Mechanism of human SIRT1 activation by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Substrate-specific activation of sirtuins by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 activation by small molecules: kinetic and biophysical evidence for direct interaction of enzyme and activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sirt1 activation by resveratrol is substrate sequence-selective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Evidence for a common mechanism of SIRT1 regulation by allosteric activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol stimulates AMP kinase activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves health and survival of mice on a high-calorie diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol stimulates glucose transport in C2C12 myotubes by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

AMPK: a nutrient and energy sensor that maintains energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Life-long caloric restriction elicits pronounced protection of the aged myocardium: a role for AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol as a calorie restriction mimetic: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

LKB1/STRAD promotes axon initiation during neuronal polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

PKA phosphorylates and inactivates AMPKalpha to promote efficient lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

PKA/AMPK signaling in relation to adiponectin's antiproliferative effect on multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Calorie restriction mimicking effects of roflumilast prevents diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol and life extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol affects differently rat liver and brain mitochondrial bioenergetics and oxidative stress in vitro: investigation of the role of gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Direct activation of ATM by resveratrol under oxidizing conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

ATM activation by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effects of resveratrol on longevity, cognitive ability and aging-related histological markers in the annual fish Nothobranchius guentheri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The lifespan extension effects of resveratrol are conserved in the honey bee and may be driven by a mechanism related to caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Red wine and equivalent oral pharmacological doses of resveratrol delay vascular aging but do not extend life span in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Caloric restriction delays disease onset and mortality in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sirt1 protects against high-fat diet-induced metabolic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SirT1 gain of function increases energy efficiency and prevents diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Retracted: Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Beta-cell PDE3B regulates Ca2+-stimulated exocytosis of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Alterations in regulation of energy homeostasis in cyclic nucleotide phosphodiesterase 3B-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Reduced adiposity and high-fat diet-induced adipose inflammation in mice deficient for phosphodiesterase 4B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves insulin signaling in a tissue-specific manner under insulin-resistant conditions only: in vitro and in vivo experiments in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SRT1720 improves survival and healthspan of obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol supplementation improves white adipose tissue function in a depot-specific manner in Zucker diabetic fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents β-cell dedifferentiation in nonhuman primates given a high-fat/high-sugar diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Molecular inflammation: underpinnings of aging and age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Type 2 diabetes as an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol: a multitargeted agent for age-associated chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Are sirtuins viable targets for improving healthspan and lifespan?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Mammalian SIRT1 represses forkhead transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan-polysaccharide rat model of Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Calorie restriction and resveratrol in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Upregulation and activation of eNOS by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents hyperglycemia-induced endothelial dysfunction via activation of adenosine monophosphate-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Role of SIRT1 and FOXO factors in eNOS transcriptional activation by resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol induces mitochondrial biogenesis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effects of resveratrol on NO secretion stimulated by insulin and its dependence on SIRT1 in high glucose cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effects of intravenous ABT-870 (iron (III)-hydroxide oligosaccharide) on mean arterial pressure and heart rate in the anaesthetized beagle: comparison with other iron-containing haematinic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two-kidney, one-clip hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Protective effect of resveratrol on oxidative damage in male and female stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents high fat/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Inhibition of neointimal formation by trans-resveratrol: role of phosphatidyl inositol 3-kinase-dependent Nrf2 activation in heme oxygenase-1 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol increases vascular oxidative stress resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol inhibits interleukin-6 production in cortical mixed glial cells under hypoxia/hypoglycemia followed by reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Idebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

SIRT1 activation confers neuroprotection in experimental optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol delays Wallerian degeneration in a NAD(+) and DBC1 dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Wine, alcohol, platelets, and the French paradox for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Absorption of three wine-related polyphenols in three different matrices by healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol levels and all-cause mortality in older community-dwelling adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Therapeutic potential of resveratrol: the in vivo evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

?-Glucuronidase activity in trained red and white skeletal muscle of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Pharmacology, physiology, and mechanisms of incretin hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The role of the PDE4D cAMP phosphodiesterase in the regulation of glucagon-like peptide-1 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Pilot study of resveratrol in older adults with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

An antiinflammatory and reactive oxygen species suppressive effects of an extract of Polygonum cuspidatum containing resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Small molecule SIRT1 activators for the treatment of aging and age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

The NAD(+)/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-014-1808-8

Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence

21 January 2018

1 reference

12 December 2020

Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment

1 reference

12 December 2020

Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus

1 reference

12 December 2020

Effects of stilbenes on arachidonate metabolism in leukocytes

1 reference

12 December 2020

Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats

1 reference

12 December 2020

Constitutive SIRT1 overexpression impairs mitochondria and reduces cardiac function in mice

1 reference

12 December 2020

Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network

1 reference

12 December 2020

Calorie restriction and aging: review of the literature and implications for studies in humans

1 reference

12 December 2020

Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol.

1 reference

12 December 2020

Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation

1 reference

12 December 2020

Inhibition of human LDL oxidation by resveratrol

1 reference

12 December 2020

AMP-activated protein kinase phosphorylation of endothelial NO synthase

1 reference

12 December 2020

The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes.

1 reference

12 December 2020

Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats

1 reference

12 December 2020

Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease.

1 reference

12 December 2020

Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4).

1 reference

12 December 2020

Resveratrol attenuates oxLDL-stimulated NADPH oxidase activity and protects endothelial cells from oxidative functional damages

1 reference

12 December 2020

Is resveratrol an estrogen agonist in growing rats?

1 reference

12 December 2020

The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935

1 reference

12 December 2020

Effects of resveratrol on the rat brain respiratory chain.

1 reference

12 December 2020

Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

In vitro effects of genistein and resveratrol on the production of interferon-gamma (IFNgamma) and interleukin-10 (IL-10) by stimulated murine splenocytes

1 reference

12 December 2020

Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model

1 reference

12 December 2020

Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta

1 reference

12 December 2020

Altered mitochondrial energy metabolism may play a role in vascular aging

1 reference

12 December 2020

10.1007/S00018-014-1808-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25548801%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference